Submission Details
| 510(k) Number | K180438 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | February 20, 2018 |
| Decision Date | March 20, 2018 |
| Days to Decision | 28 days |
| Submission Type | Special |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
K180438 is an FDA 510(k) clearance for the BD Veritor System for Rapid Detection of Flu A + B CLIA waived kit, a Devices Detecting Influenza A, B, And C Virus Antigens (Class II — Special Controls, product code PSZ), submitted by Bd (San Diego, US). The FDA issued a Cleared decision on March 20, 2018, 28 days after receiving the submission on February 20, 2018. This device falls under the Microbiology review panel. Regulated under 21 CFR 866.3328.
| 510(k) Number | K180438 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | February 20, 2018 |
| Decision Date | March 20, 2018 |
| Days to Decision | 28 days |
| Submission Type | Special |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
| Product Code | PSZ — Devices Detecting Influenza A, B, And C Virus Antigens |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 866.3328 |
| Definition | An Influenza Virus Antigen Detection Test System Is A Device Intended For The Qualitative Detection Of Influenza Viral Antigens Directly From Clinical Specimens In Patients With Signs And Symptoms Of Respiratory Infection. |